These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9797683)

  • 1. Primary association of HLA-B51 with Behçet's disease in Ireland.
    Benezra D
    Br J Ophthalmol; 1998 Jun; 82(6):715. PubMed ID: 9797683
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary association of HLA-B51 with Behçet's disease in Ireland.
    Kilmartin DJ; Finch A; Acheson RW
    Br J Ophthalmol; 1997 Aug; 81(8):649-53. PubMed ID: 9349151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B51 negative monozygotic twins discordant for Behçet's disease.
    Gül A; Inanç M; Ocal L; Aral O; Carin M; Koniçe M
    Br J Rheumatol; 1997 Aug; 36(8):922-3. PubMed ID: 9291866
    [No Abstract]   [Full Text] [Related]  

  • 4. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101.
    Mizuki N; Inoko H; Ando H; Nakamura S; Kashiwase K; Akaza T; Fujino Y; Masuda K; Takiguchi M; Ohno S
    Am J Ophthalmol; 1993 Oct; 116(4):406-9. PubMed ID: 8213969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome.
    Arber N; Klein T; Meiner Z; Pras E; Weinberger A
    Ann Rheum Dis; 1991 Jun; 50(6):351-3. PubMed ID: 2059078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of HLA with Behçet's disease and its significance].
    Si CW; Wong JH; Xi HL
    Zhonghua Nei Ke Za Zhi; 1988 Jun; 27(6):363-5, 390-1. PubMed ID: 3197510
    [No Abstract]   [Full Text] [Related]  

  • 7. A complete type patient with Behçet's disease associated with HLA-B*5102.
    Mizuki N; Inoko H; Ishihara M; Ando H; Nakamura S; Nishio M; Ohno S
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):757-8. PubMed ID: 7747590
    [No Abstract]   [Full Text] [Related]  

  • 8. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice.
    Takeno M; Kariyone A; Yamashita N; Takiguchi M; Mizushima Y; Kaneoka H; Sakane T
    Arthritis Rheum; 1995 Mar; 38(3):426-33. PubMed ID: 7880197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behçet's disease in Italian patients.
    Kera J; Mizuki N; Ota M; Katsuyama Y; Pivetti-Pezzi P; Ohno S; Inoko H
    Tissue Antigens; 1999 Dec; 54(6):565-71. PubMed ID: 10674970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on HLA system of family members with Behçet's disease].
    Ohno S; Ichiishi A; Awata K; Matsuda H
    Nippon Ganka Gakkai Zasshi; 1989 Feb; 93(2):215-7. PubMed ID: 2773703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A strong association between HLA-B*5101 and Behçet's disease in Greek patients.
    Mizuki N; Ohno S; Ando H; Chen L; Palimeris GD; Stavropoulos-Ghiokas E; Ishihara M; Goto K; Nakamura S; Shindo Y; Isobe K; Ito N; Inoko H
    Tissue Antigens; 1997 Jul; 50(1):57-60. PubMed ID: 9243757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran.
    Rajaei E; Jalali MT; Pezeshki SMS; Rezaeeyan H; Maniati M; Elyasi M; Zayeri ZD
    Curr Rheumatol Rev; 2020; 16(2):120-124. PubMed ID: 31533601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behçet's disease.
    Sano K; Yabuki K; Imagawa Y; Shiina T; Mizuki N; Ohno S; Kulski JK; Inoko H
    Tissue Antigens; 2001 Aug; 58(2):77-82. PubMed ID: 11696219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B51 frequency in Iranian patients with Behçet's disease.
    Shahram F; Davatchi F; Nadji A; Jamshidi A; Bahar K; Akbarian M; Chams C
    Adv Exp Med Biol; 2003; 528():229-30. PubMed ID: 12918696
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome.
    Chajek-Shaul T; Pisanty S; Knobler H; Matzner Y; Glick M; Ron N; Rosenman E; Brautbar C
    Am J Med; 1987 Oct; 83(4):666-72. PubMed ID: 3314492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of HLA-B51 with clinical expression of Behçet's disease. Analysis of 201 Iranian patients.
    Shahram F; Davatchi F; Nadji A; Jamshidi A; Bahar K; Akbarian M; Gharibdoost F
    Adv Exp Med Biol; 2003; 528():147-8. PubMed ID: 12918680
    [No Abstract]   [Full Text] [Related]  

  • 17. Behçet's disease in East African patients may not be unusual and is an HLA-B51 negative condition: a case series from Mayotte (Comoros).
    Liozon E; Roussin C; Puéchal X; Garou A; Valadier P; Périnet I; Raffray L; Théry Y; De Lagarde B
    Joint Bone Spine; 2011 Mar; 78(2):166-70. PubMed ID: 20599413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behçet's disease in patients of German and Turkish origin--a comparative study.
    Kötter I; Vonthein R; Günaydin I; Müller C; Kanz L; Zierhut M; Stübiger N
    Adv Exp Med Biol; 2003; 528():53-8. PubMed ID: 12918660
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of familial occurrence of Behçet's disease with and without ocular lesions.
    Nishiyama M; Nakae K; Umehara T
    Jpn J Ophthalmol; 2001; 45(3):313-6. PubMed ID: 11369384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behcet's disease associated with HLA-B51 and DRw52 antigens in Italians.
    Baricordi OR; Sensi A; Pivetti-Pezzi P; Perrone S; Balboni A; Catarinelli G; Filippi F; Melchiorri L; Moncada A; Mattiuz PL
    Hum Immunol; 1986 Nov; 17(3):297-301. PubMed ID: 2432045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.